Search

everythinglearnresearchcommunity

for

Search:↓

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

AH-001 could be a safer and more effective treatment for hair loss.

Both treatments for alopecia areata are equally effective and safe.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The inhibitor affects androgen metabolism but not ovarian function.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

GRF is not safe for tubal occlusion.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Blocking interferon-gamma might help treat various autoimmune diseases.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.